Prestige Consumer Healthcare Current Ratio 2012-2025 | PBH
Prestige Consumer Healthcare current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Prestige Consumer Healthcare Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.50B | $0.14B | 3.70 |
| 2025-06-30 | $0.48B | $0.11B | 4.38 |
| 2025-03-31 | $0.45B | $0.11B | 4.21 |
| 2024-12-31 | $0.38B | $0.10B | 3.68 |
| 2024-09-30 | $0.38B | $0.11B | 3.56 |
| 2024-06-30 | $0.37B | $0.11B | 3.23 |
| 2024-03-31 | $0.38B | $0.12B | 3.20 |
| 2023-12-31 | $0.39B | $0.13B | 3.09 |
| 2023-09-30 | $0.39B | $0.13B | 2.99 |
| 2023-06-30 | $0.39B | $0.15B | 2.66 |
| 2023-03-31 | $0.39B | $0.16B | 2.44 |
| 2022-12-31 | $0.41B | $0.16B | 2.55 |
| 2022-09-30 | $0.34B | $0.15B | 2.21 |
| 2022-06-30 | $0.33B | $0.16B | 2.09 |
| 2022-03-31 | $0.29B | $0.14B | 2.05 |
| 2021-12-31 | $0.28B | $0.14B | 2.04 |
| 2021-09-30 | $0.31B | $0.15B | 2.05 |
| 2021-06-30 | $0.41B | $0.13B | 3.27 |
| 2021-03-31 | $0.27B | $0.12B | 2.21 |
| 2020-12-31 | $0.30B | $0.13B | 2.39 |
| 2020-09-30 | $0.27B | $0.14B | 1.98 |
| 2020-06-30 | $0.30B | $0.13B | 2.24 |
| 2020-03-31 | $0.37B | $0.15B | 2.44 |
| 2019-12-31 | $0.30B | $0.15B | 2.02 |
| 2019-09-30 | $0.31B | $0.15B | 2.08 |
| 2019-06-30 | $0.31B | $0.14B | 2.16 |
| 2019-03-31 | $0.30B | $0.13B | 2.37 |
| 2018-12-31 | $0.29B | $0.13B | 2.28 |
| 2018-09-30 | $0.32B | $0.15B | 2.16 |
| 2018-06-30 | $0.31B | $0.14B | 2.21 |
| 2018-03-31 | $0.30B | $0.12B | 2.46 |
| 2017-12-31 | $0.33B | $0.15B | 2.19 |
| 2017-09-30 | $0.33B | $0.16B | 2.06 |
| 2017-06-30 | $0.33B | $0.15B | 2.14 |
| 2017-03-31 | $0.33B | $0.16B | 2.06 |
| 2016-12-31 | $0.29B | $0.13B | 2.20 |
| 2016-09-30 | $0.28B | $0.11B | 2.45 |
| 2016-06-30 | $0.28B | $0.10B | 2.81 |
| 2016-03-31 | $0.25B | $0.11B | 2.33 |
| 2015-12-31 | $0.23B | $0.09B | 2.63 |
| 2015-09-30 | $0.21B | $0.09B | 2.21 |
| 2015-06-30 | $0.20B | $0.10B | 1.98 |
| 2015-03-31 | $0.20B | $0.10B | 2.04 |
| 2014-12-31 | $0.20B | $0.09B | 2.21 |
| 2014-09-30 | $0.22B | $0.11B | 1.99 |
| 2014-06-30 | $0.16B | $0.08B | 2.04 |
| 2014-03-31 | $0.18B | $0.08B | 2.10 |
| 2013-12-31 | $0.25B | $0.13B | 1.82 |
| 2013-09-30 | $0.18B | $0.09B | 2.05 |
| 2013-06-30 | $0.16B | $0.08B | 1.99 |
| 2013-03-31 | $0.16B | $0.10B | 1.70 |
| 2012-12-31 | $0.15B | $0.09B | 1.70 |
| 2012-09-30 | $0.18B | $0.09B | 2.03 |
| 2012-06-30 | $0.14B | $0.06B | 2.29 |
| 2012-03-31 | $0.15B | $0.06B | 2.30 |
| 2011-12-31 | $0.11B | $0.05B | 2.00 |
| 2011-09-30 | $0.11B | $0.06B | 2.00 |
| 2011-06-30 | $0.10B | $0.05B | 2.05 |
| 2011-03-31 | $0.11B | $0.05B | 1.99 |
| 2010-12-31 | $0.18B | $0.05B | 3.99 |
| 2010-09-30 | $0.12B | $0.03B | 3.84 |
| 2010-06-30 | $0.10B | $0.03B | 3.65 |
| 2010-03-31 | $0.11B | $0.06B | 2.02 |
| 2009-12-31 | $0.11B | $0.04B | 2.93 |
| 2009-09-30 | $0.11B | $0.05B | 2.24 |
| 2009-06-30 | $0.10B | $0.04B | 2.90 |
| 2009-03-31 | $0.10B | $0.03B | 3.03 |
| 2008-12-31 | $0.10B | $0.04B | 2.60 |
| 2008-09-30 | $0.09B | $0.04B | 2.31 |
| 2008-06-30 | $0.08B | $0.03B | 2.50 |
| 2008-03-31 | $0.09B | $0.04B | 2.25 |
| 2007-12-31 | $0.09B | $0.04B | 2.24 |
| 2007-09-30 | $0.09B | $0.05B | 1.99 |
| 2007-06-30 | $0.08B | $0.04B | 2.20 |
| 2007-03-31 | $0.08B | $0.04B | 2.05 |
| 2006-12-31 | $0.08B | $0.04B | 1.93 |
| 2006-09-30 | $0.08B | $0.04B | 1.90 |
| 2006-06-30 | $0.09B | $0.04B | 2.52 |
| 2006-03-31 | $0.09B | $0.04B | 2.41 |
| 2005-12-31 | $0.09B | $0.04B | 2.57 |
| 2005-09-30 | $0.10B | $0.04B | 2.67 |
| 2005-06-30 | $0.09B | $0.03B | 2.58 |
| 2005-03-31 | $0.08B | $0.04B | 2.02 |
| 2004-12-31 | $0.00B | 0.00 | |
| 2004-09-30 | $0.00B | 0.00 | |
| 2004-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.086B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.959B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $150.458B | 0.00 |
| Boston Scientific (BSX) | United States | $144.746B | 33.10 |
| Stryker (SYK) | United States | $140.556B | 27.91 |
| Medtronic (MDT) | Ireland | $125.035B | 17.32 |
| Medline (MDLN) | United States | $53.232B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.704B | 0.00 |
| Agilent Technologies (A) | United States | $42.105B | 26.62 |
| GE HealthCare Technologies (GEHC) | United States | $39.758B | 19.01 |
| ResMed (RMD) | United States | $36.846B | 25.50 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $21.735B | 24.47 |
| Insulet (PODD) | United States | $20.333B | 63.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.401B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.263B | 0.00 |
| Baxter (BAX) | United States | $10.831B | 8.74 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.735B | 31.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.480B | 13.65 |
| BillionToOne (BLLN) | United States | $3.933B | 0.00 |
| Envista Holdings (NVST) | United States | $3.885B | 22.29 |
| Haemonetics (HAE) | United States | $3.840B | 17.09 |
| ICU Medical (ICUI) | United States | $3.777B | 23.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.286B | 14.69 |
| Neogen (NEOG) | United States | $2.093B | 45.81 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.928B | 38.81 |
| Curaleaf Holdings (CURLF) | Canada | $1.716B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.680B | 73.64 |
| Phibro Animal Health (PAHC) | United States | $1.599B | 15.97 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.577B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.425B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| BioLife Solutions (BLFS) | United States | $1.197B | 355.14 |
| Capricor Therapeutics (CAPR) | United States | $1.090B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.031B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.005B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Omeros (OMER) | United States | $0.886B | 0.00 |
| CeriBell (CBLL) | United States | $0.865B | 0.00 |
| Valneva SE (VALN) | France | $0.850B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.563B | 15.26 |
| Verano Holdings (VRNO) | United States | $0.461B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| Brainsway (BWAY) | Israel | $0.453B | 77.03 |
| Cresco Labs (CRLBF) | United States | $0.443B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.396B | 0.00 |
| Quanterix (QTRX) | United States | $0.376B | 0.00 |
| Evolus (EOLS) | United States | $0.366B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.290B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 21.94 |
| Sanuwave Health (SNWV) | United States | $0.266B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.242B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| High Tide (HITI) | Canada | $0.234B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Vireo Growth (VREOF) | United States | $0.208B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Accendra Health (ACH) | United States | $0.190B | 1.91 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Apyx Medical (APYX) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| MacroGenics (MGNX) | United States | $0.116B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.71 |
| ImmuCell (ICCC) | United States | $0.059B | 24.98 |
| Sharps Technology (STSS) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.051B | 37.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.53 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |